Removal of isoagglutinin antibodies from plasma avoids the requirement to match plasma to the blood type of the recipient.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

Together, HemCon and ProMetic will develop and validate a sterile, single-use antibody capture device for the removal of isoagglutinin antibodies.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

If isoagglutinin antibody removal is combined with the HemCon LyP System, a novel plasma preservation system, which provides human plasma in a freeze-dried form, it would provide a stable and universally applicable plasma for emergency use.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

Tuesday, March 3, 2009, 10: 59am PST HemCon Medical Technologies Inc. on Tuesday announced a development agreement with a company in England to develop a sterile, single-use antibody capture device for the removal of isoagglutinin antibodies.    From Wordnik.com.  [Portland Business News - Local Portland News | The Portland Business Journal] Reference

The project with HemCon Medical Technologies, Inc. to develop a sterile, single-use antibody capture device for the removal of isoagglutinin antibodies initiated in March 2009 met its first development milestone and moved into the second phase of development.    From Wordnik.com.  [Marketwire - Breaking News Releases]